Yarrow Bioscience, Inc. ("Yarrow" or the "Company") , a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today announced the ...
VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has declared a special cash dividend (the “Cash Dividend”) in connection with the previously ...
VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its previously announced special cash dividend (the “Cash Dividend”), declared in connection with the terms and ...
Just seven years into operation, Daxing airport, Beijing's youngest airport, has grown into one of China's largest and ...
VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its previously announced special cash dividend (the "Cash Dividend") ...
VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") today announced that its Board of Directors has approved a reverse stock split of VYNE's common ...
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE)-- VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE” or the "Company”) today announced that its Board of Directors has approved a reverse stock split of VYNE’s ...
The world-renowned academic institution has nothing to say in response to a six-month investigation by Byline Times raising serious concerns about the safeguarding of students and foreign influence at ...
MAYOR of Kingston Andrew Swaby is one of the 46 mayors from 15 countries selected for the 10th class of the Bloomberg Harvard ...
The amylin analogs and combination therapies competitive landscape report delivers important insights into approved as well as ongoing research of 20+ pipeline amylin analogs and combination therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results